2. Academic Validation
  3. An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'

An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'

  • Bioorg Med Chem Lett. 2013 Jun 1;23(11):3411-5. doi: 10.1016/j.bmcl.2013.03.066.
Warunya Arunotayanun 1,  Jeffrey W Dalley,  Xi-Ping Huang,  Vincent Setola,  Ric Treble,  Leslie Iversen,  Bryan L Roth,  Simon Gibbons
Affiliations

Affiliation

  • 1 Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.
PMID: 23602445 DOI: 10.1016/j.bmcl.2013.03.066
Abstract

Novel Psychoactive Drugs (NPD) can be sold without restriction and are often synthetic analogues of controlled drugs. The tryptamines are an important class of NPD as they bind to the various serotonin (5-HT) receptor subtypes and cause psychosis and hallucinations that can lead to injury or death through misadventure. Here we report on the structure elucidation and receptor binding profiles of two widely marketed tryptamine-derived NPDs, namely alpha-methyl-tryptamine and 5-methoxy-N,N-diallyl-tryptamine.

Figures